Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 1995 | 2017 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2007 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.130 | None | 1.000 | 3 | 0 | 2000 | 2019 | ||||||||
|
EWS RNA binding protein 1 | 0.474 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 1997 | 2020 | ||||||||
|
NGFI-A binding protein 2 | 0.641 | 0.577 | 0.57 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 1994 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1993 | 2001 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2015 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2011 | 2019 | ||||||||
|
synaptotagmin 1 | 0.412 | 0.846 | 0.60 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2006 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 1997 | 2014 | ||||||||
|
TLE family member 1, transcriptional corepressor | 0.560 | 0.654 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2013 | ||||||||
|
forkhead box O1 | 0.433 | 0.846 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2012 | ||||||||
|
SS18 subunit of BAF chromatin remodeling complex | 0.641 | 0.462 | 0.75 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2006 | ||||||||
|
GLI family zinc finger 1 | 0.431 | 0.846 | 7.7E-14 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2014 | ||||||||
|
FUS RNA binding protein | 0.470 | 0.846 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2012 | ||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2002 |